{"id":"W2008621188","doi":"10.1158/0008-5472.sabcs-09-201","title":"Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Taxane; Internal medicine; Breast cancer; Lapatinib; Sunitinib; Cancer; Neutropenia; Pharmacokinetics; Metastatic breast cancer; Dosing; Clinical endpoint; Trastuzumab; Pharmacology; Oncology; Gastroenterology; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001882601,0.0008105804,0.001809152,0.0004143653,0.0003785848,0.0008015991,0.0005337956,0.0008876625,0.002405965],"category_scores_gemma":[0.0009968138,0.0004390162,0.0009636428,0.0004659527,0.0006239268,0.000632396,0.0002491579,0.001348512,0.0004460581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006297328,"about_ca_system_score_gemma":0.000852639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000662921,"about_ca_topic_score_gemma":0.001675322,"domain_scores_codex":[0.9995407,0.0002380348,0.00004142354,0.00006512812,0.0000509219,0.00006378004],"domain_scores_gemma":[0.9993024,0.0001422517,0.000188952,0.00005654641,0.00003708616,0.0002728421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6364772,0.05745466,0.02392304,0.001797243,0.003465033,0.0006295369,0.000490106,0.003353219,0.06477907,0.0002218907,0.004252384,0.2031567],"study_design_scores_gemma":[0.398612,0.5516288,0.03612699,0.00005944624,0.001348705,0.001048242,0.00008753277,0.00189908,0.006155148,0.0001421558,0.002856374,0.00003549396],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960473,0.002097297,0.0002425326,0.0001445742,0.00003089114,0.0005119123,0.0003165678,0.00004236896,0.0005664531],"genre_scores_gemma":[0.9954801,0.001768692,0.0005580306,0.0002446815,0.00008118588,0.0004582737,0.000766375,0.00001400051,0.0006287437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002405965,"threshold_uncertainty_score":0.009956241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06576479026102895,"score_gpt":0.4372951659954871,"score_spread":0.3715303757344581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}